Item 5.02 Departure of Directors or Principal Officers; Election of Directors;
Appointment of Principal Officers; Compensatory Arrangements of Certain Officers.

Appointment of new principal accounting officer

On March 9, 2009, our company appointed Deno G. Bokas, Vice President Finance and Chief Accounting Officer, as its Principal Accounting Officer. We delayed filing this report, under instructions to Item 5.02 of Form 8-K, to the date we issued our press release attached as Exhibit 99.1 announcing his appointment. Mr. Bokas, 46, joined the company as a full-time employee in January 2009.

Prior to joining our company, Mr. Bokas was an independent consultant providing financial services largely to pharmaceutical and equipment device companies. From November 2007 to May 2008, Mr. Bokas served as Vice President Finance and Corporate Controller of Aradigm Corporation, a publicly traded pharmaceutical company. Prior to that he was Vice President and Controller for Perlegen Sciences, a pre-IPO genetics services company. From December 2004 to September 2006, Mr. Bokas served in an SEC reporting and accounting capacity at Xenogen Corporation, a publicly traded scientific device and research company. Mr. Bokas was Chief Financial Officer for the National Railroad Passenger Corporation from 2002 to 2004. Mr. Bokas earned a Master of Science Finance Degree from Walsh College and a Bachelor of Business Administration Degree from Eastern Michigan University. He is also a Certified Public Accountant.